Clinical Trials in Pennsylvania

Showing 7501-7520 of 19,675 trials

Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning

NCT06028152

The goal of this clinical trial is to explore feasibility, acceptability, and effectiveness of end-of-life conversation game "Hello" as a tool to help individuals with breast, lung, and/or genito-urinary cancers treated at Penn State Cancer Institute and their loved ones perform advance care planning. The main questions it aims to answer are: * What modifications and/or adaptations are necessary to Hello for use in cancer populations? * How do different delivery models compare for recruitment in terms of feasibility and efficiency? Participants will: * Complete pre-game questionnaires * Play the Hello game * Complete post-game questionnaires * Participate in a focus group

Breast CancerLung CancerGenito Urinary Cancer

Milton S. Hershey Medical Center14 participantsStarted Oct 2023

Hershey, Pennsylvania, United States

COMPLETEDNA61 miles

Electrically Evoked Compound Action Potentials Human Observation Medtronic Algorithm Comparison Study

NCT04765735

This is a prospective, multi-center, randomized, single-blind, cross-over, non-significant risk IDE research study to evaluate the in-clinic performance of a closed-loop algorithm in Spinal Cord Stimulation (SCS) therapy with an ENS device.

Chronic Pain

MedtronicNeuro52 participantsStarted Feb 2021

Carlsbad, California, United States • Duluth, Minnesota, United States • Edina, Minnesota, United States +6 more locations

Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning

Electrically Evoked Compound Action Potentials Human Observation Medtronic Algorithm Comparison Study

Find Trials by Condition in Pennsylvania

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy Adults

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

OCS Lung System EXPAND II Trial

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer

Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer

A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia

An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis

CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone

RF Ablation of the Trigone for the Treatment of UUI

A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer

Cardionomic STOP-ADHF Study

A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)

ALPN-202 With PD-1 Inhibition in Advanced Malignancies

Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)